
Spravato® (Esketamine Nasal Spray)
Spravato is an FDA‑approved, clinician‑administered nasal spray treatment indicated for adults with treatment‑resistant depression (TRD) and major depressive disorder (MDD) with acute suicidal ideation or behavior. It acts rapidly on NMDA receptors to enhance synaptic connectivity and mood regulation. Treatment is delivered under supervision in a certified clinical setting, starting with an induction phase (twice weekly for 4 weeks), followed by a maintenance schedule based on clinical response
Book an Appointment
About service:
Insurance & Coverage
At Psychvisit in Amityville, NY, we support comprehensive insurance coordination for Spravato:
Coverage under major insurers:
Government programs: Medicare Part B typically covers Spravato administered in-clinic (80% of allowable charges)
Private carriers: We are in-network Aetna, Cigna, United Healthcare, Empire Blue Cross Blue Shield or can pursue single-case agreements with other Insurance Carriers.
Prior Authorization Needed: Approval generally requires documentation of:
DSM‑5 diagnosis (TRD or MDD with suicidal ideation).
Trial and failure of ≥2 antidepressants (≥8 weeks each)
Clinical rating scale scores (e.g., MADRS, PHQ‑9, BDI) at baseline and during treatment.
Administration in a REMS‑certified clinical environment.
How Psychvisit Supports You:
Insurance Verification – We check your plan’s benefits and network status.
Prior Authorization Handling – We prepare and submit the necessary clinical documentation, including chart notes and assessment scores.
Benefits Maximization – We work with insurers or request single-case agreements for out-of-network plans to minimize your out-of-pocket expenses.
Cost Transparency – We clarify expected costs, including medication (Spravato kits) and facility services (administration, observation), sharing them clearly before treatment begins.
Ongoing Authorization & Monitoring – We track clinical progress and submit renewal documentation to keep your treatment ongoing without interruption.
💡 Additional Financial Support Options
Copay and deductible assistance may be available through manufacturer or Janssen CarePath programs.
Alternative payment plans, HSAs/FSAs, and other financing options can further reduce upfront costs if coverage is partial.